Treatment of relapsed acute leukemia by Ara C plus donor lymphocyte infusion using CD34＋ cells reserved at the time of allogeneic transplantation

Currently, there is no standard therapy available for relapsed acute leukemia after allogeneic hematopoietic cell transplantation (allo-HCT). In this study, we evaluated the efficacy of cytoreduction with cytarabine followed by granulocyte colony-stimulating factor (G-CSF)-primed donor lymphocyte in...

Descripción completa

Detalles Bibliográficos
Autores principales: YJ, Lee, DW, Back, HC, Cho, JH, Moon, SK, Sohn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261720/
https://www.ncbi.nlm.nih.gov/pubmed/37325245
http://dx.doi.org/10.31547/bct-2019-015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261720/
https://www.ncbi.nlm.nih.gov/pubmed/37325245
http://dx.doi.org/10.31547/bct-2019-015

Ejemplares similares